Table 3.
SUD-Related service availability during pregnancy
| Birthing hospitals (n = 7) | Prenatal care practices (n = 20) | SUD programs (n = 63)* | |||
|---|---|---|---|---|---|
| Available column % (n) |
Available column % (n) |
Available column % (n) |
Unavailable to pregnant patients only column % (n) |
Unavailable to all patients column % (n) |
|
| Buprenorphine initiation | 57.1% (4) | 25.0% (5) | 66.7% (42) | 6.3% (4) | 22.2% (14) |
| Buprenorphine maintenance | 100% (7) | 35.0% (7) | 69.8% (44) | 6.3% (4) | 22.2% (14) |
| Methadone initiation | 57.1% (4) | 0 | 47.6% (30) | 3.2% (2) | 47.6% (30) |
| Methadone maintenance | 100% (7) | 0 | 55.6% (35) | 3.2% (2) | 39.7% (25) |
| Naltrexone initiation | 42.9% (3) | 10.0% (2) | 34.9% (22) | 11.1% (7) | 50.8% (32) |
| Naltrexone maintenance | 57.1% (4) | 10.0% (2) | 36.5% (23) | 9.5% (6) | 49.2% (31) |
| Withdrawal management – alcohol/benzos | 71.4% (5) | 10.0% (2) | 34.9% (22) | 4.8% (3) | 57.1% (36) |
| Withdrawal management – opioids | 71.4% (5) | 0 | 38.1% (24) | 7.9% (5) | 49.2% (31) |
| Brief intervention (SBIRT) | 100% (7) | 50.0% (10) | 68.9% (44) | 1.6% (1) | 25.4% (16) |
| Peer recovery support | 100% (7) | 25.0% (5) | 74.6% (47) | 1.6% (1) | 23.8% (15) |
| Non-peer treatment linkage services | 71.4% (5) | 40.0% (8) | 91.9% (57) | 0 | 3.2% (2) |
| Individual SUD counseling | 0 | 25.0% (5) | 85.2% (52) | 1.6% (1) | 14.3% (9) |
| Group SUD counseling | 0 | 15.0% (3) | 74.6% (47) | 1.6% (1) | 22.2% (14) |
| Naloxone – direct distribution | 14.3% (1) | 10.0% (2) | 69.8% (44) | 3.2% (2) | 42.9% (27) |
| Naloxone – providing prescriptions | 42.9% (3) | 35.0% (7) | 50.8% (32) | 3.2% (2) | 42.9% (27) |
| Naloxone – prescribe OR distribute | 42.9% (3) | 35.0% (7) | 84.1% (53) | 3.2% (2) | 12.7% (8) |
| Other harm reduction services (e.g., providing sterile supplies) | 14.3% (1) | 5.0% (1) | 34.9% (22) | 1.6% (1) | 58.7% (37) |
*SUD program columns do not always add up to 100%, as programs could mark “Unsure/Don’t Know”